Preliminary trials indicate that Retatrutide – a dual stimulator of gut hormone and GIP receptors – may provide a substantial improvement in body loss programs . Unlike existing therapies, this dual-action compound appears to click here influence hunger and energy utilization through distinct routes. While additional copyrightination is needed